Issues in data monitoring and interim analysis of trials

Issues in data monitoring and interim analysis of trials

Bibliographic Details
Main Authors:	A Grant, D Altman, A Babiker, M Campbell, F Clemens, J Darbyshire, D Elbourne, S McLeer, M Parmar, S Pocock, D Spiegelhalter, M Sydes, A Walker, S Wallace
Format:	Article
Language:	English
Published:	NIHR Journals Library 2005-03-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta9070

Similar Items

Issues in data monitoring and interim analysis of trials.
by: Grant, A, et al.
Published: (2005)

Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials.
by: Sydes, MR, et al.
Published: (2004)

Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study.
by: Sydes, MR, et al.
Published: (2004)

Data monitoring in randomized controlled trials: surveys of recent practice and policies.
by: Clemens, F, et al.
Published: (2005)

Issues in the design and analysis of therapeutic trials in human immunodeficiency virus infection
by: Babiker, A, et al.
Published: (1998)

Monitoring of large randomised clinical trials: a new approach with Bayesian methods.
by: Parmar, M, et al.
Published: (2001)

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.
by: Piaggio, G, et al.
Published: (2006)

Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.
by: Piaggio, G, et al.
Published: (2012)

Bayesian stopping rules for trials - Reply
by: Parmar, M, et al.
Published: (2002)

Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over.
by: Curtin, F, et al.
Published: (2002)

The CONSORT statement for cluster randomised trials
by: Campbell, M, et al.
Published: (2005)

CONSORT statement: extension to cluster randomised trials.
by: Campbell, M, et al.
Published: (2004)

[The CONSORT statement for cluster randomised trials].
by: Campbell, M, et al.
Published: (2005)

Valuation of interim payment: issues encountered by the parties involved in relation to interim payment
by: Nayan, Roselan, et al.
Published: (2017)

THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES
by: M. V. Shestakova, et al.
Published: (2016-05-01)

Analysis of multivariate failure-time data from HIV clinical trials.
by: Walker, A, et al.
Published: (2000)

Consort 2010 statement: extension to cluster randomised trials.
by: Campbell, M, et al.
Published: (2012)

Markers of HIV infection in the Concorde trial. Concorde Co-ordinating Committee.
by: Walker, A, et al.
Published: (1998)

Meta-analyses involving cross-over trials: methodological issues.
by: Elbourne, DR, et al.
Published: (2002)

Gender Issues and Social Science Education - An Interim Report
by: Mechthild Oechsle, et al.
Published: (2005-08-01)

Impact of treatment changes on the interpretation of the Concorde trial.
by: White, I, et al.
Published: (1997)

Randomization-based methods for correcting for treatment changes: examples from the Concorde trial.
by: White, I, et al.
Published: (1999)

Issues encountered in the valuation of interim payment process in construction projects.
by: Mustaffa, Nur Emma, et al.
Published: (2023)

Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and Personalized Medicine
by: Julian Pinsolle, et al.
Published: (2019-10-01)

Age as a determinant of survival in HIV infection.
by: Babiker, A, et al.
Published: (2001)

The Incentive Effects of Interim Performance Evaluations
by: Lizzeri, A, et al.
Published: (2002)

Age of stratospheric air in the ERA-Interim
by: M. Diallo, et al.
Published: (2012-12-01)

Assessment of cumulative evidence on genetic associations: interim guidelines.
by: Ioannidis, J, et al.
Published: (2008)

Interim Report on S3D/LEAPS Integration
by: Chalfant, Julie, et al.
Published: (2015)

Guidance on interim analysis methods in clinical trials
by: Jody D. Ciolino, et al.
Published: (2023-01-01)

The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues
by: Editorial team Diabetes Mellitus
Published: (2016-05-01)

The Binding Nature of Interim Measures Issued by Human Rights Treaty Bodies
by: Alireza Ebrahimgol, et al.
Published: (2020-09-01)

Monitoring clinical trials. Interim data should not be publicly available.
by: Richards, S
Published: (2001)

Interim report on the research phase
by: Bassi, M
Published: (1993)

Laporan interim /
by: Universiti Teknologi Malaysia. Unit Penyelidikan dan Perundingan
Published: (1993)

Interim Revolutions
by: Daniel Sarmiento

Interim guide to quantitative risk assessment for UK reservoirs /
by: 392578 Brown, A. J., et al.
Published: (2004)

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls.
by: Pocock, S, et al.
Published: (2002)

Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes.
by: Curtin, F, et al.
Published: (2002)

Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes.
by: Curtin, F, et al.
Published: (2002)